甲氨蝶呤联合来氟米特治疗类风湿性关节炎50例临床观察(2)
 |
| 第1页 |
参见附件。
[参考文献]
[1] Arnett F C， Edworthy S M，Bloch D A， et a1.The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J].Arthritis Rheum，1988(31)：315.
[2] Cutolo M， Capellino S，Montagna P， et a1.Anti-inflammatory effeuts of leflunomide in combination with methotrexate on coculture of T lymphocytes and synovis Imacrophages from rheumatoid arthritis patients[J]. Ann Rheum Dis， 2006，65(6)：728-835.
[3] 杨德才，郑新春，王光揮，等.来氟米特与甲氨蝶呤联合用药治疗类风湿关节炎的疗效[J].中国新药与临床杂志，2004，23(1)：24-27.
[4] Cannon G W， Holden W， Juhaeri J， et a1. Adverse events with disease modifying antirheumatic drugs(DMARD)：a cohort study of leflunomide compared with other DMARD[J]. J Rheumatol， 2004，31(10)：1906-1911.
[5] American College of Rheumatology Subcommittee on Rheumatoid art Hritis Guidelines. Guidelines for the management of rheumatoid art hritis 2002 update[J]. Art Hritis Rheum，2002，46(2)：328-346.
[6] De Stefano R， Frati E， Nargi F， et a1. Comparison of combination therapies in the treatment of rheumatoid arthritis：leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha[J]. Clin Rheumatol， 2010，29(5)：517-524.
[7] Katayama K， Matsuno T. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage：retrospective comparison with methotrexate for japanese rheumatoid arthritis patients[J]. Mod Rheumatol， 2009，19(5)：513-521.
[8] Weinblatt M E， Kremer J M， Coblyn J S， et al. Pharmacokineticw，safety，and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis[J]. Arthritis Rheum， 1999，42(7)：1322-1328.
(收稿日期：2012-08-19)
您现在查看是摘要介绍页，详见PDF附件。